University of Pittsburgh Cancer Institute (UPCI)

PRC/PRMS Members

PRC/PRMS reviews are conducted by four committees. Committees A and B alternate review of therapeutic oncology trials such that one of the Committees meets every two weeks to ensure rapid review of studies and facilitate prompt progression of cancer protocols from the PRC/PRMS to the responsible IRB. Committee C reviews behavioral, cancer epidemiology, cancer control, cancer prevention, and complementary medicine protocols on an ad hoc basis, as needed. Committee E is responsible for electronic review of industry trials selected by the UPCI Director and/or Associate Director of Clinical Investigation for expedited activation, for example, a study that uses a novel agent that might benefit a patient at UPCI and is already open at other sites. The goal is to ensure that an eligible UPCI patient who might benefit from a new treatment approach is afforded the opportunity to receive the treatment in a timely fashion.

COMMITTEE A Specialty
Andrew Laman, MD (Chair) Medical Oncology (Community Physician)
Shannon L. Puhalla, MD (Vice-Chair) Hematology/Oncology
Yoshio Arai, MD Radiation Oncology
Christopher Bakkenist, PhD Radiation Oncology
Kathleen Dorritie, MD Hematology/Oncology
Melissa Hogg, MD Surgical Oncology
Annie Im, MD Hematology/Oncology
James J. Lee, MD, PhD Hematology/Oncology
Melanie Mays Senior Regulatory Specialist
Dhaval Mehta, MD Hematology/Oncology
Arjun Pennathur, MD Thoracic Surgery
Margaret Rosenzweig, PhD Oncology, Acute Care Nurse Practitioner Program (Pitt)
Ryan Smith, MD Radiation Oncology
Weijing Sun, MD Hematology/Oncology
Hong Wang, PhD Biostatistics
Amer Zureikat, MD Surgical Oncology
Ali Amjad, MD (non-voting) Fellow, Hematology/Oncology
Aju Mathew, MD (non-voting) Fellow, Hematology/Oncology


COMMITTEE B Specialty
Leonard Appleman, MD, PhD (Chair) Hematology/Oncology
Michael Boyiadzis, MD (Vice-Chair) Hematology/Oncology
Weiping DeBlasio, RN, MBA QA/QC Training Coordinator, CPDM
Daniel Johnson, PhD Hematology/Oncology
Kevin Kim, MD Interventional Radiology
Brenda Kurland, PhD Biostatistics
Jodi Maranchie, MD Urology
Katie Nason, MD, MPH Cardiothoracic Surgery
Enrico Novelli, MD Hematology/Oncology
Rahul Parikh, MD, PhD Hematology/Oncology
Linda Robertson, RN, MSN, DrPH Hematology/Oncology; Community Outreach and Advocacy
Brieana Rowles, MA CPDM Regulatory Specialist
Ronald Stoller, MD Hematology/Oncology
Ahmad Tarhini, MD, PhD Hematology/Oncology
Liza Villaruz, MD Hematology/Oncology
Hassane Zarour, MD Cancer Immunology and Cutaneous Oncology
Diwaker Davar, MD (non-voting) Fellow, Hematology/Oncology
Gaurav Goel, MD (non-voting) Fellow, Hematology/Oncology


COMMITTEE C Specialty
Linda Robertson, RN, MSN, DrPH (Chair) Hematology/Oncology; Community Outreach and Advocacy
Dana Bovbjerg, PhD Psychiatry; Biobehavioral Oncology
Reneice Gassette, BA Sr. Regulatory Specialist, CPDM
Karen Holeva, BS Research Manager, Radiation Oncology
Thomas Kensler, PhD Cancer Epidemiology and Prevention
Yan Lin, PhD Biostatistics
Donna Posluszny, PhD Hematology/Oncology; Biobehavioral Oncology
Jian-Min Yuan, MD, PhD Cancer Epidemiology and Prevention

COMMITTEE E Specialty
Andrew Laman, MD (Co-Chair) Medical Oncology (Community Physician)
Michael Boyiadzis, MD (Co-Chair) Hematology/Oncology
William Gooding, MS Biostatistics
Annie Im, MD Hematology/Oncology
Kevin Kim, MD Interventional Radiology
Jodi Maranchie, MD Urology
Daniel Normolle, PhD Biostatistics
Enrico Novelli, MD Hematology/Oncology
Liza Villaruz, MD Hematology/Oncology